WhatsApp Logo Subscribe
For News Alert

News

Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents

By AFP

April 23, 2024 01:22 PM


Twitter Share Facebook Share WhatsApp Share

 

A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for Covid vaccine technology that helped save millions of lives during the pandemic.

At issue is US firm Moderna's claim that its American competitor Pfizer and its German partner BioNTech breached patent law over its Comirnaty vaccine.

Moderna claims it is due compensation for products manufactured after March 7 last year. But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid".

The hearing is due to start at the High Court in London from 0930 GMT and is expected to last until mid-May. A ruling will come at a later date.

Moderna has filed similar patent infringement claims against Pfizer and BioNTech elsewhere, notably in the United States and Germany.

The companies earned billions of dollars from the use of cutting-edge Messenger RNA (mRNA) technology in Covid jabs.

Such vaccines work by delivering genetic instructions to turn some of the host's cells into virus-like particles, priming the immune system to mount a response.

Such vaccines were approved within months of a global pandemic being declared by the World Health Organization in March 2020.

Moderna said in 2020 that it would not enforce Covid-19-related patents while the pandemic continued.

But it announced in March last year that it expected its intellectual property to be respected in non low- and middle-income countries where supply was no longer an issue.

A Moderna spokesman on Monday said that the company will on Tuesday argue that Pfizer and BioNTech infringed two of its mRNA patents.

"Moderna is confident in the breadth, depth, and strength of its platform, which is protected by multiple patents," he told AFP.

Pfizer/BioNTech, however, are expected to argue that Moderna pledged not to sue over its Covid vaccine technology patents.


AFP


Most Read

  1. Brother shot dead over distribution of Qurbani meat in Azad Kashmir Brother shot dead over distribution of Qurbani meat in Azad Kashmir
  2. Fault in global submarine cable affects internet service in parts of Pakistan Fault in global submarine cable affects internet service in parts of Pakistan
  3. Varun Dhawan drops first love moments with baby girl Varun Dhawan drops first love moments with baby girl
  4. 30,000-litre liquor seized from container in Sharaqpur Sharif 30,000-litre liquor seized from container in Sharaqpur Sharif
  5. Former president of Landi Kotal Press Club shot dead by unknown assailants Former president of Landi Kotal Press Club shot dead by unknown assailants
  6. Diljit Dosanjh spills beans about ‘first love’ amidst marriage speculations Diljit Dosanjh spills beans about ‘first love’ amidst marriage speculations

Opinion

  1. An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!
    An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!

    By Sudheendra Kulkarni

  2. Premier Shehbaz and Chinese model
    Premier Shehbaz and Chinese model

    By Naveed Aman Khan

  3. Modi's myth broken, yet in power
    Modi's myth broken, yet in power

    By Naveed Aman Khan

  4. Xi, Shehbaz and CPEC phase - 2
    Xi, Shehbaz and CPEC phase - 2

    By Naveed Aman Khan

  5. Pakistan's UNSC Triumph: A New Era
    Pakistan's UNSC Triumph: A New Era

    By Dr Asif Channer

  6. Shehbaz, Deng, Xi and transformation
    Shehbaz, Deng, Xi and transformation

    By Naveed Aman Khan